{"id":2022,"date":"2026-08-29T19:44:09","date_gmt":"2026-08-29T19:44:09","guid":{"rendered":"https:\/\/staging.bycellmind.com\/tirzepatide-vs-retatrutide-4\/"},"modified":"2026-08-29T19:44:09","modified_gmt":"2026-08-29T19:44:09","slug":"tirzepatide-vs-retatrutide-4","status":"publish","type":"post","link":"https:\/\/staging.bycellmind.com\/hr\/tirzepatide-vs-retatrutide-4\/","title":{"rendered":"Tirzepatide vs Retatrutide: koji odabrati i za\u0161to"},"content":{"rendered":"<p>Pitanje koje sve \u010de\u0161\u0107e dolazi od istra\u017eiva\u010da i biohackera u Hrvatskoj: koja je stvarna razlika izme\u0111u Tirzepatida i Retatrutida i koji je pravi izbor za konkretni eksperiment? Odgovor nije jednostavan jer ovisi o tome \u0161to to\u010dno istra\u017eujete.<\/p>\n<h2>Temeljna razlika<\/h2>\n<p>Tirzepatide aktivira GLP-1 i GIP. Retatrutide aktivira GLP-1, GIP i Glucagon. Na papiru \u2014 jedan receptor razlike. U eksperimentalnoj praksi \u2014 dodavanje Glucagon aktivacije uvodi hepati\u010dku komponentu koja mijenja cijelu dinamiku metaboli\u010dkog odgovora.<\/p>\n<p>Tirzepatide daje \u010di\u0161\u0107i signal za prou\u010davanje GLP-1\/GIP sinergizma. Retatrutide pru\u017ea kompleksniji trojni odgovor, ali s vi\u0161e varijabli koje treba kontrolirati i potencijalno \u0161irim spektrom metaboli\u010dkih u\u010dinaka.<\/p>\n<h2>\u0160to pretklini\u010dka literatura govori o razlici?<\/h2>\n<p>Komparativne studije na \u017eivotinjskim modelima koje su koristile oba peptida bilje\u017ee:<\/p>\n<ul>\n<li>Retatrutide grupe pokazuju ve\u0107u redukciju tjelesne mase od Tirzepatide grupa u modelima pretilosti \u2014 \u0161to se pripisuje Glucagon komponenti koja poja\u010dava lipolizu<\/li>\n<li>Hepati\u010dki markeri se statisti\u010dki zna\u010dajno razlikuju izme\u0111u grupa \u2014 Retatrutide bilje\u017ei specifi\u010dne promjene u glukoneogenezi koje Tirzepatide ne pokazuje<\/li>\n<li>Inzulinska osjetljivost se pobolj\u0161ava u obje grupe, ali s druga\u010dijim profilom odgovora<\/li>\n<li>Lipidni markeri pokazuju druga\u010diji obrazac aktivacije izme\u0111u dual i triple agonista<\/li>\n<\/ul>\n<h2>Prakti\u010dni vodi\u010d za odabir<\/h2>\n<p>Odaberite Tirzepatide kada:<\/p>\n<ul>\n<li>Istra\u017eujete specifi\u010dno GLP-1\/GIP sinergizam<\/li>\n<li>Trebate izolirati dual agonisti\u010dki u\u010dinak bez Glucagon varijable<\/li>\n<li>Uspore\u0111ujete s \u010distim GLP-1 agonistima<\/li>\n<\/ul>\n<p>Odaberite Retatrutide kada:<\/p>\n<ul>\n<li>Istra\u017eujete trojnu receptorsku interakciju<\/li>\n<li>Hepati\u010dka Glucagon komponenta je relevantna za va\u0161 eksperiment<\/li>\n<li>Provodite komparativnu studiju dual vs triple aktivacije<\/li>\n<\/ul>\n<h2>Dostupnost u Hrvatskoj<\/h2>\n<p>Oba peptida dostupna su s dostavom u Hrvatsku 48\u201372 sata. Isti format \u010disto\u0107e (&gt;99% HPLC), isti format dokumentacije (CoA uz svaku narud\u017ebu), sterilna voda uklju\u010dena.<\/p>\n<p><a href=\"https:\/\/staging.bycellmind.com\/hr\/\">staging.bycellmind.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pitanje koje sve \u010de\u0161\u0107e dolazi od istra\u017eiva\u010da i biohackera u Hrvatskoj: koja je stvarna razlika izme\u0111u Tirzepatida i Retatrutida i koji je pravi izbor za konkretni eksperiment?<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","jetpack_post_was_ever_published":false},"categories":[258],"tags":[276],"class_list":["post-2022","post","type-post","status-publish","format-standard","hentry","category-blog","tag-usporedba"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/posts\/2022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/comments?post=2022"}],"version-history":[{"count":0,"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/posts\/2022\/revisions"}],"wp:attachment":[{"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/media?parent=2022"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/categories?post=2022"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/tags?post=2022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}